Narcolepsy Therapeutics Market by Disease Type (Daytime Extreme Sleepiness, Cataplexia, and Others) and Therapeutics Type (Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, and Others) Competitive Market Share & Forecast, 2020–2027

ID: VPR/A&D/287 Publishing Year: February 2021 Pages: 250 Format:   


Global narcolepsy therapeutics market was valued at $ XX billion in 2019, and is expected to reach $ XX billion by 2027, registering a CAGR of XX% from 2020 to 2027. Narcolepsy is a rare chronic neurological disorder, it is long-term sleep disorder Implies a decreased capacity to regulate sleep - wake cycles. Excessive sleepiness, hallucination, excessive daytime sleepiness, sleep deprivation and cataplexy are some symptoms of narcolepsy. However, people suffering from narcolepsy have low levels of chemicals called hypocretin (also known as orexin), which regulates sleep. Narcolepsy can be cause due to genetics, but risk of passing this disorder to child from parent is only about 1%.

According to narcolepsy network, narcolepsy is diagnosed in 1 in every 2000 people in U.S. which is around 200,000 Americans and 3 million of a global population. In addition, The effectiveness of medications for narcolepsy is not diminished by the low prevalence rate, as symptoms such as cataplexy can be life-threatening for patients with narcolepsy. These are the factors expected to boost market growth. However, Lack of information about the condition and quality of treatment is likely to hamper market growth. Inadequate access to healthcare, cost and availability of essential medicines and lack of standardized tool for diagnosis and treatment will hamper the growth of global narcolepsy market. Conversely, there are various programs, which are organized by health organizations for increasing awareness about narcolepsy which can be a boosting factor to the market.

Segment Insight

The narcolepsy therapeutics market is segmented based on disease type, therapeutics type, and regions. Based on disease type, it is classified into Daytime Extreme Sleepiness, Cataplexia, and Others. Based on therapeutics type, it is divided into Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, and Others.

By Disease Type Insight

The narcolepsy has different type of disease which are segmented into Daytime Extreme Sleepiness, Cataplexia, and Others.

By Therapeutics type Insight

The narcolepsy therapeutics market is segmented by therapeutics into Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, and Others.In addition, due to the high cost of this product it is projected to be the fastest growing segment during the forecast era.

Major key player of Narcolepsy therapeutics market

The report provides a comprehensive analysis of the key players operating in the global narcolepsy therapeutics market such as BIOPROJET PHARMA SARL,  ADDRENEX PHARMACEUTICALS, INC.,  HYPNION, INC.,  ARENA PHARMACEUTICAL, INC, LIGAND PHARMACEUTICALS INCORPORATED, JAZZ PHARMACEUTICAL PLC, NOVARTIS INTERNATIONAL AG, TAKEDA PHARMACEUTICAL COMPANY, TEVA PHARMACEUTICAL INDUSTRIES LTD., SHINOGI INC.

Most of the key players in the narcolepsy therapeutics market are focusing to attain a higher revenue share through the adoption of strategies such as mergers and acquisitions and new product development.

Narcolepsy Therapeutics Market Key Segments:

By Disease Type

  • Daytime extreme sleepiness
  • Cataplexia
  • Others

By Therapeutics Type

  • Central nervous system stimulants
  • Tricyclic antidepressants,
  • Sodium oxybate
  • Selective serotonin reuptake inhibitor
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Argentina
    • Turkey
    • South Africa
    • Rest of LAMEA

Type Here for table of content.


PURCHASE OPTIONS




    ADD TO CART

CONTACT US
CALL US ON
( +91-935-919-4956 )

CONTACT EMAIL
[email protected]
PURCHASE OPTIONS




    ADD TO CART

CONTACT US
CALL US ON
( +91-935-919-4956 )

CONTACT EMAIL
[email protected]